These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7286247)
41. [Adverse cardiovasular effects of doping in athletes]. Piłkowski S; Pokrywka A; Mamcarz A Kardiol Pol; 2008 Jan; 66(1):91-8. PubMed ID: 18266194 [No Abstract] [Full Text] [Related]
42. The drug charade. Begley S; Clifton T Newsweek; 2000 Sep; 136(11):42-5. PubMed ID: 11067259 [No Abstract] [Full Text] [Related]
43. FIFA's future activities in the fight against doping. Dvorak J; McCrory P; D'Hooghe M Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i58-9. PubMed ID: 16799106 [No Abstract] [Full Text] [Related]
44. [General practitioners and doping in sports: knowledge and attitudes]. Laure P Sante Publique; 1997 Jun; 9(2):145-56. PubMed ID: 9417372 [TBL] [Abstract][Full Text] [Related]
45. Doping in the recombinant era: strategies and counterstrategies. Azzazy HM; Mansour MM; Christenson RH Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094 [TBL] [Abstract][Full Text] [Related]
46. Doped athletes flex muscles against drug company. Schwarzberg K Nature; 2004 Aug; 430(7001):713. PubMed ID: 15306774 [No Abstract] [Full Text] [Related]
47. Declared use of medication in sports. Thuyne WV; Delbeke FT Clin J Sport Med; 2008 Mar; 18(2):143-7. PubMed ID: 18332689 [TBL] [Abstract][Full Text] [Related]
48. [Medication, athletes and doping regulations]. Hartgens F Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164 [TBL] [Abstract][Full Text] [Related]
49. A doping sinner is not always a cheat. Pluim B Br J Sports Med; 2008 Jul; 42(7):549-50. PubMed ID: 18606830 [No Abstract] [Full Text] [Related]
50. Drug misuse in sport: what the future holds. Gerrard D N Z Med J; 2008 Jul; 121(1278):11-4. PubMed ID: 18670470 [No Abstract] [Full Text] [Related]
51. Androgenic-anabolic steroids abuse in males. Di Luigi L; Romanelli F; Lenzi A J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364 [TBL] [Abstract][Full Text] [Related]
52. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Tokish JM; Kocher MS; Hawkins RJ Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585 [TBL] [Abstract][Full Text] [Related]
53. [Prevention--doping--heart groups. Sports medicine is more than pulse and blood pressure monitoring]. Stiefelhagen P MMW Fortschr Med; 2005 Jun; 147(22):4-6, 8. PubMed ID: 15977621 [No Abstract] [Full Text] [Related]
54. SCIENCE AND COMMERCIALIZED ATHLETICS. Allen WE Science; 1923 Mar; 57(1470):270-1. PubMed ID: 17820792 [No Abstract] [Full Text] [Related]
55. High school athletics. Lamont JH Wis Med J; 1987 Aug; 86(8):4. PubMed ID: 3687043 [No Abstract] [Full Text] [Related]
56. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list. Van Thuyne W; Delbeke FT Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337 [TBL] [Abstract][Full Text] [Related]
57. Distribution of caffeine levels in urine in different sports in relation to doping control. Van Thuyne W; Roels K; Delbeke FT Int J Sports Med; 2005 Nov; 26(9):714-8. PubMed ID: 16237615 [TBL] [Abstract][Full Text] [Related]
58. [Doping in sport]. Schänzer W; Thevis M Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283 [TBL] [Abstract][Full Text] [Related]
59. Drug use in athletics. Introduction. Burks TF Fed Proc; 1981 Oct; 40(12):2680-1. PubMed ID: 7286247 [No Abstract] [Full Text] [Related]